Skip to main content
. 2022 May 27;97(4):471–477. doi: 10.1016/j.abd.2021.10.002

Table 2.

Studies of remission of psoriasis after HSC transplantation.

Study number Author(s) Indication Type of HSCT Remission of psoriasis
1 Kishimoto33 Acute myeloid leukemia Allogeneic Two years of follow-up
2 Kaffenberger et al.32 Chronic myeloid leukemia Allogeneic NST Two years of follow-up
3 Kanamori et al.34 Chronic myeloid leukemia Allogeneic BMT 2.5-years of follow-up
4 Mohren et al.35 Psoriatic arthritis PBSCT 16-months
5 Woods and Mant29 Aplastic anemia Allogeneic HSCT 12-months
6 Rossi et al.36 Acute aplastic anemia Allogeneic BMT Ten years of follow-up
7 Braiteh et al.37 Multiple myeloma Autologous HSCT >2 years of follow-up
8 Held et al.38 'Ewing's sarcoma Autologous stem cell transplantation 15-months of follow-up
9 Mori et al.39 Myelodysplastic syndrome Allogeneic BMT Eight months of follow-up
10 Chen et al.40 Immunoglobulin light chain amyloidosis and psoriasis Autologous HSCT Follow-up for more than 7-years
11 Ugur and Gediz41 Psoriasis and multiple myeloma Autologous stem cell transplantation 18-months of follow-up

BMT, Bone Marrow Tansplant; HSCT, Hematopoietic Stem Cell Transplantation; NST, Nonmyeloablative allogeneic Stem cell Transplantation; PBSCT, Peripheral Blood Stem Cell Transplantation.